DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study

HAEMATOLOGICA Volume 105 Issue 9 Page 2308-2315 published_at 2020-09
アクセス数 : 1310
ダウンロード数 : 0

今月のアクセス数 : 3
今月のダウンロード数 : 0
Title
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study
Creator
Miyazaki Kana
Asano Naoko
Yamada Tomomi
Miyawaki Kohta
Sakai Rika
Igarashi Tadahiko
Nishikori Momoko
Ohata Kinya
Sunami Kazutaka
Yoshida Isao
Yamamoto Go
Takahashi Naoki
Okamoto Masataka
Yano Hiroki
Nishimura Yuki
Tamaru Satoshi
Nishikawa Masakatsu
Izutsu Koji
Kinoshita Tomohiro
Ohshima Koichi
Kato Koji
Katayama Naoyuki
Yamaguchi Motoko
Source Title
HAEMATOLOGICA
Volume 105
Issue 9
Start Page 2308
End Page 2315
Journal Identifire
ISSN 0390-6078
Language
eng
Resource Type journal article
Publisher
FERRATA STORTI FOUNDATION
Date of Issued 2020-09
Access Rights metadata only access
Relation
[DOI] 10.3324/haematol.2019.231076
[PMID] 31649127
Remark This study was supported by grants-in-aid from the Japan Agency for Medical Research and Development, AMED (the Practical Research for Innovative Cancer Control; JP15Ack0106157, JP16ck0106157, JP17ck0106157, JP18ck0106439), the Ministry of Labour, Health, and Welfare of Japan (201438142A), the director of Mie University Hospital (2012, 2013), and the National Cancer Center Research and Development Fund (26-A-4, 29-A-3).